Sponsor content
217 result(s) found, displaying 81 to 90
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Pertuzumab/trastuzumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECENTRIQ atezolizumab (rch) 840 mg/14 mL injection concentrated vial.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Risdiplam
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Satralizumab
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
-
-
Prescription medicine registrationActive ingredients: baloxavir marboxil.
-
Prescription medicine registrationActive ingredients: pertuzumab; trastuzumab.